SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1802Craig Wheeler on Teva’s Copaxone patents (from today’s 2Q08 CC): <i>“TherDewDiligence_on_SI-7/24/2008
1801SI increased about 600K in the first half of July to 6.06M shares. ijIRWIN JAMES FRANKEL-7/24/2008
1800MNTA <i>ReadMeFirst</i> updated for 2Q08 financials and disclosures DewDiligence_on_SI-7/24/2008
1799No surprise, mnta validated as first to file status: fda.gov "Glatiramerrkrw-7/23/2008
1798CS take: • What Happened: Momenta/Sandoz have filed an ANDA for a generic versimopgcw-7/13/2008
1797Controlled Chaos (MNTA, TEVA): siliconinvestor.comDewDiligence_on_SI-7/12/2008
1796My bet is that the FDA will wait for legislation on biosimilars that is anticipaidos-7/11/2008
1795Good point—I’ll change the “2009” entry in the newsflow post to “2009 or 2010.” DewDiligence_on_SI-7/11/2008
1794An FDA decision on Copaxone ANDA in '09 seems unlikely. 30 month stay due ttuck-7/11/2008
1793For patent geeks… The US Copaxone patents that MNTA/Sandoz are challenging are:DewDiligence_on_SI-7/11/2008
1792teva down $1.6B in market cap, mnta up about $60M :)rkrw-7/11/2008
1791Ok, that did it. A dual at sunset. Pick your weapon!idos-7/11/2008
1790<i>at least you can't blame hysterical Israeli investors for that :) &DewDiligence_on_SI-7/11/2008
1789well, at least you can't blame hysterical Israeli investors for that :)idos-7/11/2008
1788mnta is actually down premarket on this. Go figure :)rkrw-7/11/2008
1787Anyway no trade at TASE today.idos-7/11/2008
1786teva is only down 3-4%. Doesn't seem overdone. 3-4% of teva is much >mntarkrw-7/11/2008
1785<i>Teva is down 1.70 premarket on this. Always interesting to compare markDewDiligence_on_SI-7/11/2008
1784Teva is down 1.70 premarket on this. Always interesting to compare market cap morkrw-7/11/2008
1783Indeed.DewDiligence_on_SI-7/11/2008
1782Musings on the generic-Copaxone program: siliconinvestor.comDewDiligence_on_SI-7/11/2008
1781MNTA <i>ReadMeFirst</i> updated for FDA acceptance of Copaxone ANDA:DewDiligence_on_SI-7/11/2008
1780<b>MNTA 2008-2009 News Flow</b> <i>[Updated entry for CopaxonDewDiligence_on_SI-7/11/2008
1779Very nice.rkrw-7/11/2008
1778Copaxone ANDA has been accepted for review by FDA: biz.yahoo.comDewDiligence_on_SI-7/11/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News